HIV Vaccines Organizer(s): Andrew B. Ward, Penny L. Moore and Robin Shattock Date: March 26 - 30, 2017 Location: Sheraton Steamboat Resort, Steamboat Springs, CO, USADespite great progress in preventing and treating HIV, new infections continue to plague communities around the world, and the need for an HIV vaccine is as urgent as ever. Several large cohorts of HIV-infected individuals have enabled tremendous advances over the past five years in understanding immune responses to natural HIV infection. These advances have included the isolation of broad and potent anti-HIV antibodies, defining their developmental pathways, the generation of native-like Env trimers for immunization, and high-resolution structures of the envelope glycoprotein in complex with bnAbs. By 2017, many of these discoveries will have enabled new concepts to transition into human clinical trials, including passive monoclonal antibody therapy and novel immunization approaches. These platforms, incorporating improved technology for monitoring immune responses, will drive major advances in the vaccine field. This HIV Vaccines meeting will present the latest results from human clinical studies, along with the cutting-edge basic science behind such trials to highlight approaches that may lead to an HIV vaccine, and also reveal the molecular underpinnings of B and T cell-mediated immunity. Global Health Travel Award Deadline: October 25 2016 Scholarship Deadline: November 29 2016 Discounted Abstract Deadline: November 29 2016 Abstract Deadline: January 10 2017 Discounted Registration Deadline: January 24 2017 We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Kymab Limited
We gratefully acknowledge the generous grant for this conference provided by: National Institute of Allergy and Infectious Diseases (NIAID)Grant No. 1R13AI129592-01 Funding for this conference was made possible (in part) by AI29592-01 from the National Institute of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. |